[Form 4] Guardant Health, Inc. Insider Trading Activity
Insider sale by Guardant Health director Meghan V. Joyce. The filing shows a sale of 100 shares of Guardant Health common stock on 09/02/2025 at a price of $65.84 per share. After the transaction Ms. Joyce beneficially owned 11,183 shares, held directly. The form indicates the sale was made pursuant to a 10b5-1 plan. The filing is signed by an attorney-in-fact on behalf of the reporting person.
Vendita da parte di un insider: la direttrice di Guardant Health, Meghan V. Joyce. La comunicazione riporta la vendita di 100 azioni ordinarie di Guardant Health il 02/09/2025 al prezzo di $65,84 per azione. Dopo l'operazione la sig.ra Joyce deteneva beneficiariamente 11.183 azioni, possedute direttamente. Il modulo indica che la vendita 猫 stata effettuata in base a un piano 10b5-1. La dichiarazione 猫 firmata da un procuratore in nome della persona che effettua la segnalazione.
Venta de insider por la directora de Guardant Health, Meghan V. Joyce. El registro muestra la venta de 100 acciones ordinarias de Guardant Health el 02/09/2025 a un precio de $65.84 por acci贸n. Tras la operaci贸n, la Sra. Joyce pose铆a beneficiariamente 11.183 acciones, mantenidas directamente. El formulario indica que la venta se realiz贸 conforme a un plan 10b5-1. La presentaci贸n est谩 firmada por un apoderado en nombre de la persona que informa.
Guardant Health 鞚挫偓 氅旉贝 V. 臁办澊鞀れ潣 雮措秬鞛� 毵る弰. 鞝滌稖 靹滊鞐� 霐半ゴ氅� 2025-09-02鞐� Guardant Health 氤错喌欤� 100欤茧ゼ 欤茧嫻 $65.84鞐� 毵る弰頄堨姷雼堧嫟. 瓯半灅 鞚错泟 臁办澊鞀� 鞌姅 11,183欤茧ゼ 歆侅为 鞁れ鞝侅溂搿� 靻岇湢頃橁碃 鞛堨棃鞀惦媹雼�. 靹滊鞐愲姅 頃措嫻 毵る弰臧� 10b5-1 頂岆灉鞐� 霐半澕 鞚措（鞏挫鞚岇澊 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖 靹滊電� 鞁犼碃鞚胳潉 雽�鞁犿暅 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Vente d'initi茅 par la directrice de Guardant Health, Meghan V. Joyce. Le dossier indique la vente de 100 actions ordinaires de Guardant Health le 02/09/2025 au prix de 65,84 $ par action. Apr猫s la transaction, Mme Joyce d茅tenait, 脿 titre b茅n茅ficiaire, 11 183 actions, d茅tenues directement. Le formulaire pr茅cise que la vente a 茅t茅 r茅alis茅e conform茅ment 脿 un plan 10b5-1. Le d茅p么t est sign茅 par un mandataire agissant au nom de la personne d茅clarante.
Insider-Verkauf durch Guardant Health-Direktorin Meghan V. Joyce. Die Meldung weist den Verkauf von 100 Stammaktien von Guardant Health am 02.09.2025 zu einem Preis von $65,84 je Aktie aus. Nach der Transaktion hielt Frau Joyce wirtschaftlich 11.183 Aktien, direkt gehalten. Das Formular gibt an, dass der Verkauf im Rahmen eines 10b5-1-Plans erfolgte. Die Einreichung ist von einem Bevollm盲chtigten im Namen der meldenden Person unterschrieben.
- None.
- None.
Insights
TL;DR: Routine, small director sale executed under a 10b5-1 plan; unlikely to be material to GH valuation.
This Form 4 documents a disposition of 100 shares at $65.84, leaving the director with 11,183 shares. The checked box indicates the transaction was made pursuant to a 10b5-1 trading plan, which typically provides pre-established authorization and reduces concerns about opportunistic timing. The size of the sale (100 shares) is immaterial relative to total outstanding shares, suggesting limited informational content about company fundamentals.
TL;DR: Disclosure aligns with Section 16 obligations and shows use of an affirmative defense plan.
The filing includes required details: reporting person identity, relationship (Director), transaction date, price, and post-transaction beneficial ownership. The presence of a 10b5-1 indicator suggests the sale followed an established plan, which is a governance best practice for insiders. No other derivative or complex transactions are reported. From a governance perspective, the filing is compliant and routine.
Vendita da parte di un insider: la direttrice di Guardant Health, Meghan V. Joyce. La comunicazione riporta la vendita di 100 azioni ordinarie di Guardant Health il 02/09/2025 al prezzo di $65,84 per azione. Dopo l'operazione la sig.ra Joyce deteneva beneficiariamente 11.183 azioni, possedute direttamente. Il modulo indica che la vendita 猫 stata effettuata in base a un piano 10b5-1. La dichiarazione 猫 firmata da un procuratore in nome della persona che effettua la segnalazione.
Venta de insider por la directora de Guardant Health, Meghan V. Joyce. El registro muestra la venta de 100 acciones ordinarias de Guardant Health el 02/09/2025 a un precio de $65.84 por acci贸n. Tras la operaci贸n, la Sra. Joyce pose铆a beneficiariamente 11.183 acciones, mantenidas directamente. El formulario indica que la venta se realiz贸 conforme a un plan 10b5-1. La presentaci贸n est谩 firmada por un apoderado en nombre de la persona que informa.
Guardant Health 鞚挫偓 氅旉贝 V. 臁办澊鞀れ潣 雮措秬鞛� 毵る弰. 鞝滌稖 靹滊鞐� 霐半ゴ氅� 2025-09-02鞐� Guardant Health 氤错喌欤� 100欤茧ゼ 欤茧嫻 $65.84鞐� 毵る弰頄堨姷雼堧嫟. 瓯半灅 鞚错泟 臁办澊鞀� 鞌姅 11,183欤茧ゼ 歆侅为 鞁れ鞝侅溂搿� 靻岇湢頃橁碃 鞛堨棃鞀惦媹雼�. 靹滊鞐愲姅 頃措嫻 毵る弰臧� 10b5-1 頂岆灉鞐� 霐半澕 鞚措（鞏挫鞚岇澊 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖 靹滊電� 鞁犼碃鞚胳潉 雽�鞁犿暅 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Vente d'initi茅 par la directrice de Guardant Health, Meghan V. Joyce. Le dossier indique la vente de 100 actions ordinaires de Guardant Health le 02/09/2025 au prix de 65,84 $ par action. Apr猫s la transaction, Mme Joyce d茅tenait, 脿 titre b茅n茅ficiaire, 11 183 actions, d茅tenues directement. Le formulaire pr茅cise que la vente a 茅t茅 r茅alis茅e conform茅ment 脿 un plan 10b5-1. Le d茅p么t est sign茅 par un mandataire agissant au nom de la personne d茅clarante.
Insider-Verkauf durch Guardant Health-Direktorin Meghan V. Joyce. Die Meldung weist den Verkauf von 100 Stammaktien von Guardant Health am 02.09.2025 zu einem Preis von $65,84 je Aktie aus. Nach der Transaktion hielt Frau Joyce wirtschaftlich 11.183 Aktien, direkt gehalten. Das Formular gibt an, dass der Verkauf im Rahmen eines 10b5-1-Plans erfolgte. Die Einreichung ist von einem Bevollm盲chtigten im Namen der meldenden Person unterschrieben.
